EMA wants stakeholders’ opinions for clinical trials database

Recently, the European Medicines Agency (EMA) sent out a survey to its stakeholders asking for their opinion regarding a new clinical trials database design. The rationale for EMA asking its stakeholders for their opinions is due to new regulations that were created...